type here...

CATEGORIES

Healthcare

LATEST

1...345...75Page 4 of 75

TRENDING

EDITORS CHOICE

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life -
SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

Is Social Media to Be Trusted for Health Information?

Pat Farrell PhD -
The Internet is an incredible wealth of information, not all of it truly scientific or health-promoting, but it can prove a quick way to garner details on health matters.

Detecting Cancer With a Blood Drop

Michael Hunter, MD -
You probably got the Silicon Valley (USA) reference, but if not, here is your go-to book (full disclosure — I would love it if...

The First 28 Days. Infant Mortality’s Dead Zone

Robert Turner, Founding Editor -
The first month of life is the most vulnerable period for a babies survival. 2.4 million newborns died in 2020 in the first 28 days after birth.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories